HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.

12th Edition of International Conference on Neurology and Brain Disorders

October 20-22, 2025

October 20 -22, 2025 | Orlando, Florida, USA

Neuroleptic Malignant Syndrome

Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome (NMS) is a rare but serious side effect of antipsychotic medications that are often prescribed to treat a wide variety of mental disorders. This syndrome, which is also sometimes called neuroleptic syndrome or malignant syndrome, affects the body's nervous system and can have severely debilitating neurological, physical, and psychological consequences. While the exact cause is not completely understood, NMS is often brought on by the sudden or excessive use of antipsychotic medications. Those who are at highest risk for developing NMS are individuals who have recently changed their dosage of antipsychotic drugs, those with pre-existing medical or neurological conditions, the elderly, and people with a family history of NMS. The most common symptoms of this disorder include muscular rigidity, elevated fever, autonomic dysfunction, tremor, and altered mental status. It is important to note that not all of these symptoms have to be present in order for a diagnosis to be made. Treatment for NMS includes stopping the antipsychotic medication that triggered the syndrome, treating symptoms with antipyretic agents and benzodiazepines, and providing supportive care, such as fluids, nutrition, and ventilation if necessary. In some cases, patients may require the use of other medications to reduce their muscle rigidity and manage their psychological symptoms. It is important to recognize the signs of NMS, as it can be life-threatening if left untreated. Anyone taking an antipsychotic medication should be aware of the risk associated with this disorder and seek medical attention immediately if any of the NMS symptoms arise. Early diagnosis and prompt treatment are the key to a complete recovery.

Committee Members
Speaker at Neuroscience Conference - Ken Ware

Ken Ware

NeuroPhysics Therapy Institute and Research Centre, Australia
Speaker at Neurology and Brain Disorders - Joe Sam Robinson

Joe Sam Robinson

Mercer University, United States
Speaker at Neurology Conferences - Robert B Slocum

Robert B Slocum

University of Kentucky HealthCare, United States
INBC 2025 Speakers
Speaker at Brain Disorders Conference - Thomas J Webster

Thomas J Webster

Interstellar Therapeutics, United States
Speaker at Neuroscience Conference - Roger H Coletti

Roger H Coletti

Interventional Health, PA, United States
Speaker at Neuroscience Conference - Stephen Grossberg

Stephen Grossberg

Boston University, United States
Speaker at Brain Disorders Conference - George Diaz

George Diaz

Memorial Healthcare Systems, United States
Tags

Submit your abstract Today

Watsapp